Melatonin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510241865

Publication Date:

October 9, 2024

Pages:

139

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Melatonin API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Melatonin API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Melatonin API by region & country, by Type, and by Application.
The Melatonin API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melatonin API.
Market Segmentation
By Company
Merck KGaA
Caesar & Loretz GmbH
EVONIK
Bio-Techne Corp.
Cayman Chemical Company (Matreya)
Spectrum Chemical
Caesar & Loretz GmbH
LGM Pharma
Flavine Europe GmbH
Ralington Pharma
SimSon Pharma Limited
Santa Cruz Biotechnology, Inc.
Biosynth
Otto Chemie Pvt. Ltd.
Pharmaffiliates Analytics and Synthetics P. Ltd.
Clearsynth Labs
Segment by Type:
Natural
Synthetic
Segment by Application
Biotechnology Company
Pharmaceutical Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Melatonin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Melatonin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Melatonin API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Melatonin API Product Introduction
1.2 Global Melatonin API Market Size Forecast
1.2.1 Global Melatonin API Sales Value (2019-2030)
1.2.2 Global Melatonin API Sales Volume (2019-2030)
1.2.3 Global Melatonin API Sales Price (2019-2030)
1.3 Melatonin API Market Trends & Drivers
1.3.1 Melatonin API Industry Trends
1.3.2 Melatonin API Market Drivers & Opportunity
1.3.3 Melatonin API Market Challenges
1.3.4 Melatonin API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Melatonin API Players Revenue Ranking (2023)
2.2 Global Melatonin API Revenue by Company (2019-2024)
2.3 Global Melatonin API Players Sales Volume Ranking (2023)
2.4 Global Melatonin API Sales Volume by Company Players (2019-2024)
2.5 Global Melatonin API Average Price by Company (2019-2024)
2.6 Key Manufacturers Melatonin API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Melatonin API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Melatonin API
2.9 Melatonin API Market Competitive Analysis
2.9.1 Melatonin API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Melatonin API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melatonin API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Natural
3.1.2 Synthetic
3.2 Global Melatonin API Sales Value by Type
3.2.1 Global Melatonin API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Melatonin API Sales Value, by Type (2019-2030)
3.2.3 Global Melatonin API Sales Value, by Type (%) (2019-2030)
3.3 Global Melatonin API Sales Volume by Type
3.3.1 Global Melatonin API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Melatonin API Sales Volume, by Type (2019-2030)
3.3.3 Global Melatonin API Sales Volume, by Type (%) (2019-2030)
3.4 Global Melatonin API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biotechnology Company
4.1.2 Pharmaceutical Company
4.1.3 Others
4.2 Global Melatonin API Sales Value by Application
4.2.1 Global Melatonin API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Melatonin API Sales Value, by Application (2019-2030)
4.2.3 Global Melatonin API Sales Value, by Application (%) (2019-2030)
4.3 Global Melatonin API Sales Volume by Application
4.3.1 Global Melatonin API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Melatonin API Sales Volume, by Application (2019-2030)
4.3.3 Global Melatonin API Sales Volume, by Application (%) (2019-2030)
4.4 Global Melatonin API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Melatonin API Sales Value by Region
5.1.1 Global Melatonin API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Melatonin API Sales Value by Region (2019-2024)
5.1.3 Global Melatonin API Sales Value by Region (2025-2030)
5.1.4 Global Melatonin API Sales Value by Region (%), (2019-2030)
5.2 Global Melatonin API Sales Volume by Region
5.2.1 Global Melatonin API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Melatonin API Sales Volume by Region (2019-2024)
5.2.3 Global Melatonin API Sales Volume by Region (2025-2030)
5.2.4 Global Melatonin API Sales Volume by Region (%), (2019-2030)
5.3 Global Melatonin API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Melatonin API Sales Value, 2019-2030
5.4.2 North America Melatonin API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Melatonin API Sales Value, 2019-2030
5.5.2 Europe Melatonin API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Melatonin API Sales Value, 2019-2030
5.6.2 Asia Pacific Melatonin API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Melatonin API Sales Value, 2019-2030
5.7.2 South America Melatonin API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Melatonin API Sales Value, 2019-2030
5.8.2 Middle East & Africa Melatonin API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Melatonin API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Melatonin API Sales Value
6.2.1 Key Countries/Regions Melatonin API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Melatonin API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Melatonin API Sales Value, 2019-2030
6.3.2 United States Melatonin API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Melatonin API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Melatonin API Sales Value, 2019-2030
6.4.2 Europe Melatonin API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Melatonin API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Melatonin API Sales Value, 2019-2030
6.5.2 China Melatonin API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Melatonin API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Melatonin API Sales Value, 2019-2030
6.6.2 Japan Melatonin API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Melatonin API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Melatonin API Sales Value, 2019-2030
6.7.2 South Korea Melatonin API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Melatonin API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Melatonin API Sales Value, 2019-2030
6.8.2 Southeast Asia Melatonin API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Melatonin API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Melatonin API Sales Value, 2019-2030
6.9.2 India Melatonin API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Melatonin API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Company Information
7.1.2 Merck KGaA Introduction and Business Overview
7.1.3 Merck KGaA Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck KGaA Melatonin API Product Offerings
7.1.5 Merck KGaA Recent Development
7.2 Caesar & Loretz GmbH
7.2.1 Caesar & Loretz GmbH Company Information
7.2.2 Caesar & Loretz GmbH Introduction and Business Overview
7.2.3 Caesar & Loretz GmbH Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Caesar & Loretz GmbH Melatonin API Product Offerings
7.2.5 Caesar & Loretz GmbH Recent Development
7.3 EVONIK
7.3.1 EVONIK Company Information
7.3.2 EVONIK Introduction and Business Overview
7.3.3 EVONIK Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 EVONIK Melatonin API Product Offerings
7.3.5 EVONIK Recent Development
7.4 Bio-Techne Corp.
7.4.1 Bio-Techne Corp. Company Information
7.4.2 Bio-Techne Corp. Introduction and Business Overview
7.4.3 Bio-Techne Corp. Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bio-Techne Corp. Melatonin API Product Offerings
7.4.5 Bio-Techne Corp. Recent Development
7.5 Cayman Chemical Company (Matreya)
7.5.1 Cayman Chemical Company (Matreya) Company Information
7.5.2 Cayman Chemical Company (Matreya) Introduction and Business Overview
7.5.3 Cayman Chemical Company (Matreya) Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cayman Chemical Company (Matreya) Melatonin API Product Offerings
7.5.5 Cayman Chemical Company (Matreya) Recent Development
7.6 Spectrum Chemical
7.6.1 Spectrum Chemical Company Information
7.6.2 Spectrum Chemical Introduction and Business Overview
7.6.3 Spectrum Chemical Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Spectrum Chemical Melatonin API Product Offerings
7.6.5 Spectrum Chemical Recent Development
7.7 Caesar & Loretz GmbH
7.7.1 Caesar & Loretz GmbH Company Information
7.7.2 Caesar & Loretz GmbH Introduction and Business Overview
7.7.3 Caesar & Loretz GmbH Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Caesar & Loretz GmbH Melatonin API Product Offerings
7.7.5 Caesar & Loretz GmbH Recent Development
7.8 LGM Pharma
7.8.1 LGM Pharma Company Information
7.8.2 LGM Pharma Introduction and Business Overview
7.8.3 LGM Pharma Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 LGM Pharma Melatonin API Product Offerings
7.8.5 LGM Pharma Recent Development
7.9 Flavine Europe GmbH
7.9.1 Flavine Europe GmbH Company Information
7.9.2 Flavine Europe GmbH Introduction and Business Overview
7.9.3 Flavine Europe GmbH Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Flavine Europe GmbH Melatonin API Product Offerings
7.9.5 Flavine Europe GmbH Recent Development
7.10 Ralington Pharma
7.10.1 Ralington Pharma Company Information
7.10.2 Ralington Pharma Introduction and Business Overview
7.10.3 Ralington Pharma Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Ralington Pharma Melatonin API Product Offerings
7.10.5 Ralington Pharma Recent Development
7.11 SimSon Pharma Limited
7.11.1 SimSon Pharma Limited Company Information
7.11.2 SimSon Pharma Limited Introduction and Business Overview
7.11.3 SimSon Pharma Limited Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SimSon Pharma Limited Melatonin API Product Offerings
7.11.5 SimSon Pharma Limited Recent Development
7.12 Santa Cruz Biotechnology, Inc.
7.12.1 Santa Cruz Biotechnology, Inc. Company Information
7.12.2 Santa Cruz Biotechnology, Inc. Introduction and Business Overview
7.12.3 Santa Cruz Biotechnology, Inc. Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Santa Cruz Biotechnology, Inc. Melatonin API Product Offerings
7.12.5 Santa Cruz Biotechnology, Inc. Recent Development
7.13 Biosynth
7.13.1 Biosynth Company Information
7.13.2 Biosynth Introduction and Business Overview
7.13.3 Biosynth Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Biosynth Melatonin API Product Offerings
7.13.5 Biosynth Recent Development
7.14 Otto Chemie Pvt. Ltd.
7.14.1 Otto Chemie Pvt. Ltd. Company Information
7.14.2 Otto Chemie Pvt. Ltd. Introduction and Business Overview
7.14.3 Otto Chemie Pvt. Ltd. Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Otto Chemie Pvt. Ltd. Melatonin API Product Offerings
7.14.5 Otto Chemie Pvt. Ltd. Recent Development
7.15 Pharmaffiliates Analytics and Synthetics P. Ltd.
7.15.1 Pharmaffiliates Analytics and Synthetics P. Ltd. Company Information
7.15.2 Pharmaffiliates Analytics and Synthetics P. Ltd. Introduction and Business Overview
7.15.3 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Pharmaffiliates Analytics and Synthetics P. Ltd. Melatonin API Product Offerings
7.15.5 Pharmaffiliates Analytics and Synthetics P. Ltd. Recent Development
7.16 Clearsynth Labs
7.16.1 Clearsynth Labs Company Information
7.16.2 Clearsynth Labs Introduction and Business Overview
7.16.3 Clearsynth Labs Melatonin API Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Clearsynth Labs Melatonin API Product Offerings
7.16.5 Clearsynth Labs Recent Development
8 Industry Chain Analysis
8.1 Melatonin API Industrial Chain
8.2 Melatonin API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Melatonin API Sales Model
8.5.2 Sales Channel
8.5.3 Melatonin API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck KGaA
Caesar & Loretz GmbH
EVONIK
Bio-Techne Corp.
Cayman Chemical Company (Matreya)
Spectrum Chemical
Caesar & Loretz GmbH
LGM Pharma
Flavine Europe GmbH
Ralington Pharma
SimSon Pharma Limited
Santa Cruz Biotechnology, Inc.
Biosynth
Otto Chemie Pvt. Ltd.
Pharmaffiliates Analytics and Synthetics P. Ltd.
Clearsynth Labs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂